Premier Research competitors

August Troendle is a Chairman/President/CEO/Founder at Medpace and is based in Ohio. He has worked as Board Member at Xenon Pharmaceuticals Inc. and Board Member at COHERUS BIOSCIENCES, INC.. August studied at University of Maryland.

Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies. Prior to joining Parexel, Mr. Macdonald served as CEO of INC Research, now known as Syneos Health, from January 2013 through September 2016, where he led the company through a successful Initial Public Offering in 2014. Mr. Macdonald also served as INC’s Chief Operating Officer from July 2011 through December 2012, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this, he held various senior operational and finance roles at Quintiles. He has previously served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and as its Chairman in 2015. Mr. Macdonald’s recent experience also includes serving as Chairman of the Board for Certara, a drug development consultancy with solutions spanning discovery, preclinical and clinical drug development, from 2017 to 2018. Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Colin Shannon is President, Chief Executive Officer (CEO) and Director for PRA. Since 2007, Mr. Shannon has served as President and Chief Operating Officer (COO) for PRA. Mr. Shannon has contributed significantly to the development of PRA's current mission and vision. As COO, he has been instrumental in driving PRA's decision-making processes and building a talented pool of clinical professionals.

Robert Davie is a Chief Executive Officer at Pharm Olam International and is based in Watford, Hertfordshire, United Kingdom. He has worked as VP/Gen Mgr:Global Clinical Development at COVANCE INC.